LATEST TRIALS

  • Solide Tumores
    Safety and pharmacokinetics of ODM-207 in patienst with selected advanced tumors; an open-label, non-randomosed, uncontrolled, multicentre, first-in-human study with cohort expansion
  • Sarcoma
    A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Trial of Crenolanib in Subjects with Advanced or Metastatic Gastrointestinal Stromal Tumors with a D842V Mutation in the PDGFRA Gene
  • Head And Neck Cancer
    A Double-Blind, Randomized, Two Arm Phase 2 Study of Nivolumab in Combination with Ipilimumab versus Nivolumab in Combination with Ipilimumab Placebo In Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

NORDIC COOPERATION

Norway Norway Sweden Finland Aarhus Herlev Copenhagen